Zsófia Kohajda Selected Research

Ventricular Tachycardia

1/2016	The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
1/2012	Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zsófia Kohajda Research Topics

Disease

3	Torsades de Pointes (Torsade de Pointes) 01/2021 - 01/2012
3	Cardiac Arrhythmias (Arrythmia) 01/2016 - 01/2012
2	Ischemia 02/2021 - 01/2016
2	Ventricular Tachycardia 01/2016 - 01/2012
1	Atrial Fibrillation 01/2022
1	Hypoxia (Hypoxemia) 02/2021
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2016
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2016
1	Andersen Syndrome 07/2015
1	Paralysis (Palsy) 07/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2015

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
2	dofetilide (Tikosyn)FDA Link 01/2016 - 01/2012
1	Carbachol (Carbastat)FDA Link 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2021
1	Adenosine Triphosphate (ATP)IBA 02/2021
1	PotassiumIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	ORM-10962IBA 01/2016
1	Sodium-Calcium ExchangerIBA 01/2016
1	Ouabain (G Strophanthin)IBA 01/2016
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 07/2015
1	Diclofenac (SR 38)FDA LinkGeneric 01/2012